NF-κB p65 represses β-catenin-activated transcription of cyclin D1

Injoo Hwang1, Yong Seok Choi, Mi-Ya Jeon

  • 1National Research Lab for RNA Cell Biology, BK21 Graduate Program for RNA Biology, Institute of Nanosensor and Biotechnology and Department of Molecular Biology, Dankook University, Gyeonggi-do 448-701, Republic of Korea.

Insights

This study reveals that nuclear factor-kappa B (NF-κB) can inhibit beta-catenin

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Gene Regulation

Background:

  • The beta-catenin and NF-κB signaling pathways are crucial in cellular processes.
  • Crosstalk between these pathways is known to exist.
  • Their interaction on shared target genes remains less understood.

Purpose of the Study:

  • To investigate the functional crosstalk between beta-catenin and NF-κB on their common target genes.
  • To elucidate the mechanism of this interaction at the promoter level.

Main Methods:

  • Utilized the cyclin D1 promoter as a model system.
  • Employed gene reporter assays to measure transcriptional activity.
  • Performed chromatin immunoprecipitation to assess protein binding to DNA.

Main Results:

  • Beta-catenin activated transcription from the cyclin D1 promoter.
  • NF-κB p65 significantly reduced beta-catenin-mediated transcription.
  • NF-κB p65 diminished beta-catenin binding to the cyclin D1 promoter, suggesting protein-protein interaction.

Conclusions:

  • NF-κB and beta-catenin exhibit functional crosstalk on shared target genes like cyclin D1.
  • NF-κB can antagonize beta-catenin's transcriptional activity through promoter binding interference.
  • This dynamic interplay is critical for regulating target gene expression.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...